Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Bibliographic Details
Main Authors: Michele Mishto, Guillermo Rodriguez-Hernandez, Jacques Neefjes, Henning Urlaub, Juliane Liepe
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
proteasome
peptide splicing
antigen presentation
tumor immunology
mass spectrometry
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.679836/full
id doaj-ed00d8bd3da842e7b734fbc4cc606cba
record_format Article
spelling doaj-ed00d8bd3da842e7b734fbc4cc606cba2021-07-13T13:56:40ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-07-011210.3389/fimmu.2021.679836679836Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer PatientsMichele Mishto0Michele Mishto1Guillermo Rodriguez-Hernandez2Guillermo Rodriguez-Hernandez3Jacques Neefjes4Henning Urlaub5Henning Urlaub6Juliane Liepe7Centre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King’s College London, London, United KingdomFrancis Crick Institute, London, United KingdomCentre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King’s College London, London, United KingdomFrancis Crick Institute, London, United KingdomDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center (LUMC), Leiden, NetherlandsMax-Planck-Institute for Biophysical Chemistry, Göttingen, GermanyBioanalytics, Institute of Clinical Chemistry, University Medical Center, Göttingen, GermanyMax-Planck-Institute for Biophysical Chemistry, Göttingen, Germanyhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.679836/fullproteasomepeptide splicingantigen presentationtumor immunologymass spectrometry
collection DOAJ
language English
format Article
sources DOAJ
author Michele Mishto
Michele Mishto
Guillermo Rodriguez-Hernandez
Guillermo Rodriguez-Hernandez
Jacques Neefjes
Henning Urlaub
Henning Urlaub
Juliane Liepe
spellingShingle Michele Mishto
Michele Mishto
Guillermo Rodriguez-Hernandez
Guillermo Rodriguez-Hernandez
Jacques Neefjes
Henning Urlaub
Henning Urlaub
Juliane Liepe
Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
Frontiers in Immunology
proteasome
peptide splicing
antigen presentation
tumor immunology
mass spectrometry
author_facet Michele Mishto
Michele Mishto
Guillermo Rodriguez-Hernandez
Guillermo Rodriguez-Hernandez
Jacques Neefjes
Henning Urlaub
Henning Urlaub
Juliane Liepe
author_sort Michele Mishto
title Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_short Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_fullStr Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full_unstemmed Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_sort response: commentary: an in silico–in vitro pipeline identifying an hla-a*02:01+ kras g12v+ spliced epitope candidate for a broad tumor-immune response in cancer patients
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-07-01
topic proteasome
peptide splicing
antigen presentation
tumor immunology
mass spectrometry
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.679836/full
work_keys_str_mv AT michelemishto responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT michelemishto responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT guillermorodriguezhernandez responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT guillermorodriguezhernandez responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT jacquesneefjes responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT henningurlaub responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT henningurlaub responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT julianeliepe responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
_version_ 1721305434590019584

Similar Items